2 active not recruiting, 2 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Active not recruiting 2, Completed 2 |
Follow Jynneos: new trials by email Literature Review of Jynneos trials Research Report on Jynneos
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells Jynneos, MVA-BN (Quail) - Monkeypox (Mpox) | Phase 2 | Active not recruiting | Bavarian Nordic | 970 | 2025-10-27 | 2026-04-08 |
| A Phase 2 Randomized Multisite Trial to Inform Public Health Strategies Involving the Use of MVA-BN Vaccine for Mpox JYNNEOS - Monkeypox | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 450 | 2023-03-22 | 2026-03-27 |
| Trial to Evaluate the Immunogenicity of Dose Reduction Strategies of the MVA-BN Monkeypox Vaccine JYNNEOS - Monkeypox | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 229 | 2022-09-09 | 2026-04-16 |
| Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS Tecovirimat, Smallpox and Mpox Vaccine, Placebo - Smallpox | Phase 2 | Active not recruiting | SIGA Technologies | 100 | 2022-04-05 | 2026-09-14 |
Mpox, Monkeypox (3) · Smallpox (1)
National Institute of Allergy and Infectious Diseases (NIAID) (2) · Bavarian Nordic (1) · SIGA Technologies (1)
United States (4) · Puerto Rico (1)